AVXL Straddle Strategy
AVXL (Anavex Life Sciences Corp.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Operating as a clinical-stage biopharmaceutical entity, Anavex Life Sciences Corp. specializes in developing therapeutic drug candidates for various central nervous system (CNS) conditions. Its leading compound, ANAVEX 2-73, is currently in advanced development, undergoing Phase III clinical evaluation for both Alzheimer's disease and pediatric Rett syndrome. This same drug is also in Phase II trials for Parkinson's disease and is being explored in preclinical studies for a wider range of disorders, including epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. Another significant drug candidate, ANAVEX 3-71, has progressed to Phase I clinical trials for frontotemporal dementia and other forms of dementia, with additional preclinical investigation underway for neurodegenerative illnesses like Alzheimer's and Parkinson's. The company's earlier-stage portfolio includes ANAVEX 1-41, a sigma-1 receptor agonist targeting depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand with potential applications in neuropathic and visceral pain; and ANAVEX 1037, aimed at treating prostate and pancreatic cancers. Anavex Life Sciences Corp. was founded in 2004 and maintains its headquarters in New York, New York.
AVXL (Anavex Life Sciences Corp.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $298.4M, a beta of 1.14 versus the broader market, a 52-week range of 2.255-10.4, average daily share volume of 1.1M, a public-listing history dating back to 2006, approximately 34 full-time employees. These structural characteristics shape how AVXL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.14 places AVXL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on AVXL?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
AVXL snapshot
As of August 14, 2026, spot at $3.21, ATM IV 79.60%, IV rank 15.79%, expected move 22.82%. The straddle on AVXL below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this straddle structure on AVXL specifically: AVXL IV at 79.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a AVXL straddle, with a market-implied 1-standard-deviation move of approximately 22.82% (roughly $0.73 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AVXL expiries trade a higher absolute premium for lower per-day decay. Position sizing on AVXL should anchor to the underlying notional of $3.21 per share and to the trader's directional view on AVXL stock.
AVXL straddle setup
The AVXL straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AVXL at $3.21 on that close, the first option leg uses a $3.21 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AVXL chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AVXL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $3.21 | N/A |
| Buy 1 | Put | $3.21 | N/A |
AVXL straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
AVXL straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on AVXL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on AVXL
Straddles on AVXL are pure-volatility plays that profit from large moves in either direction; traders typically buy AVXL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
AVXL thesis for this straddle
The market-implied 1-standard-deviation range for AVXL extends from approximately $2.48 on the downside to $3.94 on the upside. A AVXL long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current AVXL IV rank near 15.79% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AVXL at 79.60%. As a Healthcare name, AVXL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AVXL-specific events.
AVXL straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AVXL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AVXL alongside the broader basket even when AVXL-specific fundamentals are unchanged. Always rebuild the position from current AVXL chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on AVXL?
- A straddle on AVXL is the straddle strategy applied to AVXL (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With AVXL stock at $3.21 on the most recent close, the strikes shown on this page are snapped to the nearest listed AVXL chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are AVXL straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the AVXL straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 79.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a AVXL straddle?
- The breakeven for the AVXL straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The AVXL market-implied 1-standard-deviation expected move in the same options snapshot is approximately 22.82%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on AVXL?
- Straddles on AVXL are pure-volatility plays that profit from large moves in either direction; traders typically buy AVXL straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current AVXL implied volatility affect this straddle?
- AVXL ATM IV is at 79.60% with IV rank near 15.79%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.